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Mammalian aging is characterized by a myriad of 
changes that span many levels of complexity: from 
molecules to organ systems.  With age, damage to DNA 
and proteins, misfolding, misprocessing and 
mistargeting of key macromolecules all increase, while 
the timely repair and degradation of defective 
components decline [1-4].  Old differentiated cells lose 
their functionality while stem and progenitor cells 
dedicated to generating new differentiated cells lose 
their regenerative capacity [5, 6].  The cumulative 
molecular and cellular changes which are characteristic 
of mammalian aging result in the widespread decline 
in organ function and the inevitable death of the 
organism. Such intrinsic aging seems unavoidable, 
since it is caused simply by utilizing (over a particular 
period of time) the physiological signaling pathways 
necessary for cell function and survival, for example, 
the mTOR pathway, IGF/insulin pathway or Reactive 





































The silver lining to the gathering clouds of aging seems 
to be the relative youth of organ stem cells.  Organ stem 
cells are sequestered sometime during embryonic 
development to remain undifferentiated yet dedicated to 
a particular cell lineage, and these cells reside in their 
tissue niches, which they maintain and repair typically 
throughout adult life.  Organ stem cells self-renew via 
asymmetric cell divisions, where one daughter cell 
differentiates while the other remains a stem cell. The 
regenerative capacity of organ stem cells is very 
efficient in embryonic and young organisms, but 
deteriorates with advancing age, and the cell-extrinsic 
changes, i.e. the aging of the stem cell niche, play a 
large role in that age-specific decline. For example, it 
was found that satellite cells (muscle stem cells), 
residing in old muscle do not irreversibly lose their 
ability for tissue repair, and in contrast are capable of 
robust myogenesis when these cells are exposed to the 
external environments typical of a young mammal [13-














Abstract: Although  functional  organ  stem  cells  persist  in  the  old,  tissue  damage  invariably  overwhelms  tissue  repair,




control of  cell  cycle  check point  proteins  and mitogens, which need  to  be  tightly  balanced  in  order  to promote  tissue
regeneration without tumor formation. While responses of adult stem cells are regulated extrinsically and age‐specifically,
we  put  forward  experimental  evidence  suggesting  that  embryonic  cells  have  an  intrinsic  youthful  barrier  to  aging  and
produce  soluble  pro‐regenerative  proteins  that  signal  the  MAPK  pathway  for  rejuvenating  myogenesis.    Future
identification of this activity will  improve our understanding of embryonic versus adult regulation of tissue regeneration
suggesting  novel  strategies  for  organ  rejuvenation.  Comprehensively,  the  current  intersection  of  aging  and  stem  cell
science indicates that if the age‐imposed decline in the regenerative capacity of stem cells was understood, the debilitating
lack of organ maintenance in the old could be ameliorated and perhaps, even reversed.  
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chronic parabiosis, where aged mice are exposed to 
young blood circulation, was demonstrated to enhance 
endogenous regeneration in muscle and liver [14, 19].  
Similarly undefined, in molecular terms, transplantation 
of human embryonic stem cells (hESC) into the muscle 
of old mice rejuvenated repair after injury in vivo [20].  
More defined conditions, such as activation of IGF-1 or 
Notch, or MAPR/pERK pathways and attenuation TGF- 
β signaling and Wnt signaling were reported to awaken 
the regenerative responses of the aged muscle stem cells 
[11, 13, 17-19, 21].  All these conditions are generally 
mitogenic, suggesting that efficient proliferation is one 
key component in the regenerative responses of organ 
stem cells. Likewise, genetic inactivation of the cyclin-
dependent kinase (CDK) inhibitor, p16 was shown to 
rejuvenate responses of tissue dedicated stem cells in 
blood, brain and pancreas, while the over-expression of 
p16 caused premature aging of lymphocytes [22-26].  
These findings suggest that aged tissue imposes a state 
of anti-proliferation on the organ stem cells, which then 
logically prevents their regenerative performance.  A 
high threshold for stem cell activation in an old niche 
might be a very important adaptation as a barrier to 
cancer. Since DNA damage accumulates with time and 
translates into mutations in dividing cells, it would be 
beneficial to limit the process of regeneration, thus 
limiting the numbers of dividing stem and progenitor 
cells in a given tissue, because such cells could 
potentially deviate into neoplasty. In concert with this 
notion is the complex behavior of the senescent niche, 
in which the cell secretome changes in response to 
DNA damage and potentially adapts tissue to such 
damage.  Senescent cells undergo growth arrest via cell-
intrinsic and extrinsic (cytokine-imposed) mechanisms, 
which initially suppresses tumorogenesis and inhibits 
tissue regenerative responses; however, with prolonged 
time in senescence, some of the secreted molecules, 
such as IL6, IL8 and MMPs enhance tissue repair, and 
promote tumor progression. While the senescent niche 
can signal its own clearance via the immune system, 
some senescent cells persist and produce cytokines, 
causing chronic inflammation and tissue aging [27-29]. 
 
 Interestingly, the expression of moderately increased 
levels of p19ARF/p53 cell-cycle inhibitors in transgenic 
mice that also over-express telomerase promoted the 
longevity and decreased the biomarkers of aging [30]. 
These results suggest that determinants of healthy and 
prolonged life might be under a combinatorial control of 
cell cycle check point proteins and mitogens, where the 
activities of these reciprocal regulators of cell division 
need to be tightly balanced. 
Comprehensively, current research at the cross-roads of 
aging and stem cell biology hints that if the molecular 
changes causal to the age-imposed decline in the 
responses of organ stem cells were understood, the 
debilitating phenotypes of aging that are caused by the 
abandonment of tissue maintenance, could be 
ameliorated and perhaps, even reversed.   
 
The key age-specific changes in signal transduction are 
relatively well understood in skeletal muscle: old 
myofibers fail to up-regulate the Notch ligand, Delta, in 
response to muscle damage, and in addition, 
overproduce TGF-β, which boosts the levels of CDK 
inhibitors in satellite cells thus suppressing muscle 
regeneration [16].  Remarkably, these biochemical 
features of stem cell aging are conserved between mice 
and humans [18].  Thus, the lessons learned in the 
mouse system are likely to be applicable for 
understanding human aging and for developing novel 
anti-aging clinical strategies. In human muscle it is the 
age-specific loss of MAPK/pERK signaling strength 
that precludes the up-regulation of Delta and activation 
of Notch in old satellite cells which consequentially fail 
to recognize the need to regenerate muscle [18].    
 
The interactions between MAPK and Delta/Notch 
signaling are also conserved between mammals and 
Drosophila, where the MAPK pathway is similarly 
required for the induction of Delta and activation of 
Notch leading to increased cell proliferation [13, 18, 31, 
32].  Interestingly, however, while in mice and humans 
active MAPK and Notch signify stem cell youth and 
these pathways become lacking with aging, in adult 
flies, the up-regulation of MAPK and active Notch 
actually occurs during aging and accounts for an age-
specific hyper-proliferation of stem cells in the intestine 
[13, 18, 31].  
 
 Published results also establish that there is an age-
specific increase in systemic TGF-β, which intriguingly 
is also evolutionary conserved between mice and 
humans [17].  These same data point out that TGF-β is 
likely to exert its inhibitory affects on satellite cells 
through the local muscle niche or when tissue is 
wounded and platelets release this cytokine [17].  
Notably, the same work defines that Wnt, which was 
also reported to inhibit satellite cell myogenicity, 
neither increases with age systemically, nor is present in 
blood serum of mice and humans [17, 19].  Other 
systemic pro-inflammatory cytokines, such as TNF-a  
and IL-6, were reported to become over-pronounced in 
the aged mammals, and it would be interesting to 
determine their contribution to the decline in the 
regenerative responses of old organ stem cells [33].  
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The relative intrinsic youth of tissue stem cells in an old 
organism is not typical just for muscle and indeed is 
manifested, for example, by epidermal stem cells [34]. 
Similarly, the dominant age-specific role of the niche 
over the stem cell properties is not unique to muscle and 
is displayed, for example, in oogenesis [35-37]. Hence, 
strategies aimed to boost the performance of organ stem 
cells in aged tissues might succeed in general terms for 
rejuvenating tissue maintenance and repair throughout 
an old organism.  
 
One approach for achieving the youthful responses of 
organ stem cells in an old mammal might enlist the help 
of bioengineering, for example, to generate bio-
polymers that would release TGF-β antagonists, Notch 
and/or MAPK agonists, etc. at precise doses and rates.  
This is technically feasible, and biopolymers releasing 
cytokines, chemokines, nucleic acids, and antibodies 
were successfully tested in vivo for a variety of 
applications ranging from regenerative medicine to anti-
cancer treatments [38-40]. The in vivo applications of 
anti-aging biomaterials would protect tissue stem cells 
against the aged biochemical milieu through optimizing 
the micro-niche and would evoke efficient regenerative 
responses from old stem cells, or from young stem cells 
transplanted into aged organs. The importance of such 
biomaterials is underscored by current data suggesting 
that even young cells are doomed to perish without a 
youthful niche when introduced into an old organ [20, 
41].  Work in these directions are underway and the 
idea to provide endogenous or transplanted stem and 
progenitor cells with better micro-environments is being 
pursued by many researchers in the fields of 
regenerative medicine, material science and 
bioengineering, as well as the arena of stem cell and 
aging research [39,[40]. 
 
Tissue regeneration declines with aging throughout the 
old body, suggesting that the age-specific regulation of 
organ stem cells might be conserved between multiple 
organs. In this regard, the activation of Notch was found 
to be critically required not only for adult myogenesis, 
but also for maintenance of neural stem cells and a 
proper control of adult neurogenesis [13, 42]. Emerging 
work also suggest that the regenerative responses of 
adult stem cells in muscle and in brain are controlled by 
micro-RNAs, and that such regulation in muscle targets 
Pax7 and Pax3, while in brain the potential targets of 
micro-RNAs are the age-specific IGF and FoxO3 
pathways.  Future work on defining the age-imposed 
changes in the regulation of organ stem cells by micro-
RNAs is likely to yield a better understanding of the 
regenerative decline in the old [43-46] . 
Achieving precisely “young” levels of TGF-β, Notch 
and MAPK signaling is critically important, because 
these pathways generally regulate cell growth and 
differentiation and control p53, p21 and other CDK 
inhibitors, as well as cMyc and other pro-oncogenes 
[47-50].  Thus, deviation from the physiologic levels of 
signaling strength in these pathways is very likely to 
cause undesired changes in multiple tissues, including 
but not limited to oncogenic transformation. The risk of 
cancers is not higher, but is typically lower in younger 
mammals as compared with older ones, which suggests 
that youthful levels of the key biochemical pathways 
that regulate organ stem cell responses would result in a 
healthier and better regenerating tissue.  However 
young mammals also have less time to accumulate 
damage to DNA and other macromolecules and have 
high capacity to deal with such damage.  Hence, even if 
TGF-β, Notch, MAPK, and other mitogenic pathways 
that regulate tissue regeneration were calibrated to their 
precise “young” levels in old mammals, the expectation 
of rejuvenated, healthy tissue and perhaps, of a longer 
and cancer-free life span, needs to be justified 
experimentally. 
 
In practical terms, not enough is known about the 
identity and the expression profile of natural agonists 
and antagonists that modulate the signaling strength of 
TGF-β, Notch, MAPK and other age-specific regulators 
of stem cells in embryonic, versus adult and old 
mammals.  Hence, approaches for boosting tissue repair 
are not based on a clear understanding of the 
physiologic regulation, where robust formation of 
embryonic tissues is followed by less efficient, but still 
good, tissue regeneration in adults, and deteriorates into 
poor tissue repair in the old.  A better characterization 
of the transition from inductive to inhibitory modes of 
stem cell regulation during the progression from 
embryo to young, adult and aged mammal might help to 
uncover the key physiological molecules that modulate 
the age-specific rate of regeneration.  Ultimately, this 
would lead to novel clinical applications for safely 
enhancing tissue regeneration in the old without the side 
effects associated with non-physiological disruption in 
signal transduction. 
 
As an initial step in this direction, we put forward data 
suggesting that embryonic cells have a natural capacity 
to combat the inhibition of tissue regeneration via 
production of soluble secreted molecules and that such a 
youthful barrier to aging is lost when these cells 
differentiate. 
 
Embryonic stem cells (ESCs) have a virtually infinite 
capacity to self-renew (e.g. to give rise to another 
embryonic stem cell), and to be pluripotent (e.g. to 
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differentiate into virtually every cell type in the 
mammalian organism) [51, 52].  The tremendous 
potential of ESCs for organogenesis, including those of 
human origin (hESCs), has created great interest in 
understanding and deliberately controlling their cell fate 
determination, and tremendous  progress was made in 
recent years in this field [53, 54]. At the same time, 
much less is known about the properties of self-
renewing, undifferentiated hESCs that do not directly 
relate to developmental lineage progression, but that 
might indirectly influence the regenerative capacity of 
post-natal tissues. In this respect, our work uncovered 
that in co-cultures with mouse muscle precursor cells, 
hESCs dramatically enhanced myogenesis in vitro, and 
moreover, rejuvenated the repair of injured muscle in 
old mice when injected intramuscularly into immuno-
compromised animals, even though the hES cells 
themselves did not contribute to new muscle tissue [20]. 
The same work hinted that the positive regulation of 
mouse myogenesis by hESCs might be due to the 
soluble factors (be they protein, lipid, sugar or other 
macromolecules), and that human mesenchymal stem 
cells lack this pro-regenerative activity [20].  The data 
and discussion below introduce evidence that self-
renewing human embryonic stem cells, but not 
differentiated hESCs (hESCs vs. dhESCs), secrete 
proteins that counteract the oppressive biochemical 
milieu of aged muscle and old circulation, and restore 
efficient myogenesis to old satellite cells that associate 
with old myofibers and are exposed to old blood serum.  
Furthermore, we show that this embryonic activity 
requires an intact MAPK pathway, because the pro-
regenerative effects of hESC- secreted factors become 
abolished in the presence of a MEK inhibitor.  
Interestingly, hESC-secreted factors also promote 
proliferation and delay differentiation of primary 
myoblasts, which is a typical effect of other molecules 
known to enhance adult myogenesis, such as Notch [13, 
55, 56]. 
 
An experimental system that successfully mimics the in 
vivo myogenesis and is particularly suitable for 
comparing young and aged mammals [14, 15, 55], has 
been tailored here for characterizing the influence of 
embryonic and neonatal factors on regenerative capacity 
of satellite cells and for determining whether the 
activity is associated with proteins. Specifically, young 
and old satellite cells activated by muscle injury were 
cultured in association with their own myofibers in 
medium with 10% blood serum of their own age. These 
satellite cell cultures were maintained for 24 hours in 
HAM’s F10 supplemented with 50% OPTI MEM 
(control medium), or 50% OPTI MEM-conditioned 
medium from hESCs or dhESCs.  Exogenous MEK 
inhibitor was added to some samples to test the reliance 
of the system on MAPK pathway. BrdU was added to 
the cell cultures for the last 2 hours to label cells in S-
phase of the cell cycle.  The myogenic proliferative 
response of satellite cells was determined based on the 
percentage of proliferating myoblasts generated by the 
satellite cells (desmin+ve/BrdU+ve cells) [14, 16].  The 
enhancement of myogenic capacity was also determined 
by measuring continuous proliferation and delayed 
differentiation of myoblasts in standard differentiation 
promoting medium, by quantifying the percent of multi-
nucleated terminally differentiated eMyHC+ myotubes 
vs. BrdU+ mono-nucleated cells. Typically, more than 
50% of primary myoblasts fuse into post-mitotic multi-
nucleated myotubes in the low mitogen differentiation 
medium (DMEM+2%horse serum), however, factors 
known to boost the regenerative capacity of muscle, 
such as active Notch, can delay this terminal 
differentiation in favour of continuous progenitor cell 
proliferation [55, 56].  
 
These experiments demonstrated that secreted protein(s) 
in conditioned culture supernatants from hESCs 
manifested a pro-regenerative activity that enhanced 
and importantly, rejuvenated the regenerative capacity 
of satellite cells (Figure 1 A) and promoted the 
proliferation of myoblasts (Figure 1 B).  Interestingly, 
differentiated progeny of hESCs do not posses this pro-
regenerative anti-aging activity, as myogenic responses 
in supernatants from differentiated hESCs were no 
higher than that in control medium. The pro-
regenerative activity was also tested and not found in 
embryoid bodies, suggesting that it is general 
differentiation and not commitment to a particular 
lineage that abrogates the production of the anti-aging 
factor(s). The pro-myogenic effects of hESC 
supernatants were significantly reduced upon protease 
treatment (Proteinase K conjugated to agarose beads 
following by the removal of the beads), indicating a 
protein source of this activity. The rapid loss of the pro-
regenerative activity of hESC supernatant upon repeated 
freezing-thawing also indicates that the factors are 
labile proteins.  
 
Quite interestingly, the pro-regenerative activity was 
found to be dependent on intact MAPK signalling as 
there was no enhancement of myogenesis in the 
presence of a MEK inhibitor (Figure 1 A and B).   For 
satellite cells, inhibition of the MAPK pathway reduced 
the pro-regenerative effects of hESC supernatants on 
old satellite cells and slightly diminished the 
proliferation of young satellite cells (Figure 1A).  The 
attenuation of satellite cell proliferation by MEK 
inhibitor was partial suggesting that additional positive 
regulators of cell proliferation (for example, active 
Notch) might play a role in the studied experimental 
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system. For myoblasts, the inhibition of MAPK 
signalling prevented both proliferation and 
differentiation of the majority (~88%) of cells cultured 
with hESC supernatants (Figure 1 B), while a few cells 
(~12%) differentiated into multinucleated myotubes 
with BrdU-low nuclei.  It has been shown that MAPK 
signalling is important for the G1 to S transition, but 
once cells enter S phase, they complete cell cycle 
independently of this pathway [57]. Hence, it is 
possible that some myoblasts in the G1 phase of the 












































MEK inhibitor, even though the hESC supernatant was 
present, while myoblasts that were already in S or 
G2/M phases completed the cell cycle and 
differentiated into myotubes instead of entering into 
another G1 phase. While two different phenotypes 
were observed, in both cases the hESC-derived pro-
regenerative factors were not capable to promote 
proliferation or delay differentiation of primary 
















































supernatant  specified.    10  μM  of MEK  inhibitor was  added  to  some wells,  as  indicated.  Proliferating muscle
progenitor  cells  that  were  generated  by  the  activated  satellite  cells  were  immunodetected  with  anti‐desmin











































Summarily, these results suggest that self-renewing 
human embryonic stem cells, but not their immediately 
differentiated progeny, produce soluble pro-
regenerative protein(s) with anti-aging activity, which 
require an intact MAPK pathway for their positive 
effects on adult myogenesis. The identification of the 
pro-regenerative protein(s) is to follow, and the reliance 
of adult myogenesis on MAPK signalling suggest some 
interesting candidate gene approaches for uncovering 
natural molecules that counter the effects of aged niches 
on organ stem cells.  Molecular identification of this 
activity will broaden our knowledge of embryonic, adult 
and aged regulation of tissue regeneration and will point 
toward novel clinical strategies for organ rejuvenation 
and for improving outcomes of degenerative disorders 
where endogenous progenitor cells are overwhelmed by 







































by human cells and manifests in mouse cells, it is likely 
that the secreted proteins are evolutionarily conserved. 
 
That is interesting from a theoretical standpoint and 
provides a tractable experimental system for addressing 
the abovementioned questions.  
 
Interesting recent work suggests that a number of 
micro-RNAs attenuate the levels of SIRT-1 (a factor 
broadly implicated in senescence and aging), when 
mouse embryonic stem cells differentiate or upon a 
transition from embryonic to adult cells [58, 59]. The 
genetic and epigenetic changes between an embryonic 
versus an adult mode of tissue maintenance are likely to 
be numerous and some might explain the diminished, 
and eventually lacking, capacity for regeneration that is 
typical of human aging. 
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While it is generally believed that embryonic stem cells 
do not exist postnatally, a very interesting recent study  
reports the presence of pluripotent Oct-4+ SSEA-
1+Sca-1+Lin-CD45- very small embryonic-like stem 
cells residing in the adult murine bone marrow and 
other tissues [60]. Furthermore, it is suggested that the 
numbers of these cells, and thus the “youthful” tissue 
regenerative capacity, are under the negative regulation 
of Insulin/IGF, which fits with many studies showing an 
increase in longevity of animals that are deficient in 
Insulin/IGF [60-62].  Future work is needed to 
determine whether these embryonic-like pluripotent 
cells physiologically differentiate into various tissues in 
adults and whether there is an age-specific decline in 
this mode of postnatal organogenesis.  
 
In conclusion, the negative influence of aged 
differentiated niches (both local and systemic), on organ 
stem cell responses becomes pronounced in the old.  
Additionally, the mechanisms ensuring high performance 
of embryonic stem cells are tuned down or switched off 
later in life. One reason for such an attenuation of stem 
cell responses might be that the risk of cancer poses a 
greater threat to longevity as compared to the risk of 
diminished tissue repair.  In other words, if tissue 
regenerative capacity becomes diminished with age, there 
are fewer chances for organ stem and progenitor cells to 
deviate from their lineage commitment and generate 
tumors.  From this perspective, the age-specific decline in 
mitogenic signals, such as the embryonic pro-
regenerative activity or active Notch and MAPK 
pathways, compounded by a rise in TGF-β and CDK 
inhibitors, might have evolved to serve a protective role, 
where the fitness of a mammal is actually increased even 
though responses of muscle stem cells (and perhaps, 
other organ stem cells), are restricted. The progress of 
current research is rapidly improving our understanding 
of the properties of embryonic, adult and aged stem cells, 
and will certainly provide a better definition of the 
molecular determinants of tissue repair and maintenance. 
Ultimately, new therapies for combating and reversing 
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